ArticleCancer medicine2023

Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial.

Zhenyu Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.